1. Clinical outcome of coronavirus disease 2019 in haemato‐oncology patients. (10th June 2020) Authors: Aries, James A.; Davies, Jeffrey K.; Auer, Rebecca L.; Hallam, Simon L.; Montoto, Silvia; Smith, Matthew; Sevillano, Belen; Foggo, Vanessa; Wrench, Bela; Zegocki, Krzysztof; Agrawal, Samir; Le Dieu, Rifca; Truelove, Edward; Erblich, Thomas; Araf, Shamzah; Okosun, Jessica; Oakervee, Heather; Caven... Journal: British journal of haematology Issue: Volume 190:Number 2(2020) Page Start: e64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Durable graft‐versus‐leukaemia effects without donor lymphocyte infusions – results of a phase II study of sequential T‐replete allogeneic transplantation for high‐risk acute myeloid leukaemia and myelodysplasia. (26th October 2017) Authors: Davies, Jeff K.; Hassan, Sandra; Sarker, Shah‐Jalal; Besley, Caroline; Oakervee, Heather; Smith, Matthew; Taussig, David; Gribben, John G.; Cavenagh, Jamie D. Journal: British journal of haematology Issue: Volume 180:Number 3(2018) Page Start: 346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐term survival with low toxicity after allogeneic transplantation for acute myeloid leukaemia and myelodysplasia using non‐myeloablative conditioning without T cell depletion. (29th May 2013) Authors: Davies, Jeff K.; Taussig, David; Oakervee, Heather; Smith, Matthew; Agrawal, Samir; Cavenagh, Jamie D.; Gribben, John G. Journal: British journal of haematology Issue: Volume 162:Number 4(2013:Aug.) Page Start: 525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Myeloblative therapy with autologous haematopoietic stem cell support as consolidation of first remission in acute myeloid leukaemia – very long follow‐up. (29th July 2014) Authors: Rohatiner, Ama Z. S.; Smith, Matthew L.; Spinelli, Orietta; Rambaldi, Alessandro; Bassan, Renato; di Bona, Eros; Rodeghiero, Francesco; Raimondi, Roberto; Björkholm, Magnus; Johnson, Steve; Newland, Adrian C.; Cavenagh, Jamie D.; Macdougall, Finlay; Waters, Rachel; Fitzgibbon, Jude; Barbui, Tizia... Journal: British journal of haematology Issue: Volume 167:Number 5(2014:Dec.) Page Start: 724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long‐term follow‐up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open‐label, phase 3 trial. (6th February 2019) Authors: Cook, Gordon; Royle, Kara‐Louise; O'Connor, Sheila; Cairns, David A.; Ashcroft, A. John; Williams, Cathy D.; Hockaday, Anna; Cavenagh, Jamie D.; Snowden, John A.; Ademokun, Debo; Tholouli, Eleni; Andrews, Vivienne E.; Jenner, Matthew; Parrish, Christopher; Yong, Kwee; Cavet, Jim; Hunter, Hannah; ... Journal: British journal of haematology Issue: Volume 185:Number 3(2019) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial. (14th March 2021) Authors: Popat, Rakesh; Counsell, Nicholas; de Tute, Ruth; De‐Silva, Dunnya; Phillips, Elizabeth H.; Cavenagh, Jamie D.; Adedayo, Toyin; Braganca, Nivette; Roddie, Claire; Streetly, Matthew; Schey, Steve; Koh, Mickey B. C.; Crowe, Josephine; Morris, Treen C.; Cook, Gordon; Smith, Paul; Clifton‐Hadley, Lau... Journal: British journal of haematology Issue: Volume 193:Number 3(2021) Page Start: e19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗